drugset / Trial / NCT00296621

Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy

NCT00296621

Phase 2 Completed 30 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to determine whether long-term oral glutamine supplementation is effective in improving muscle mass and function in children with Duchenne muscular dystrophy (DMD).

Timeline

Start
2006-02
Primary completion
2008-02
Completion
2007-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutamine Other / unclassified 0.5 g/kg Oral